Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes

Oct-20

Endocrinology Neurology Pharmacoepidemiology

AUTHORS : Prof Tom Foltynie, Department of Clinical and Movement Neurosciences, UCL Institute of Neurology Queen Square, London, WC1N 3BG, UK – Email: t.foltynie@ucl.ac.uk – Profile: https://www.ucl.ac.uk/ion/research/our-departments/clinical-and-movement-neurosciences/people/prof-t-foltynie OR Prof Li Wei, UCL School of Pharmacy, 29-39 Brunswick Square London, WC1N 1AX, UK – Email: l.wei@ucl.ac.uk – Profile: https://www.ucl.ac.uk/pharmacy/people/prof-li-wei

JOURNAL : Brain

REFERENCE: 143(10):3067-3076

DOI : 10.1093/brain/awaa262

Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes

More publications

Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes